Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Gerstoft

Showing results (101-110 of 306) with videos related to

Pageof 31
Sort By:
Clinical Physiology and Functional Imaging|April 21, 2007
Carotid intima-media thickness in HIV patients treated with antiretroviral therapyAnne-Mette Lebech, Niels Wiinberg, Ulrik Sloth Kristoffersen, et al.
AIDS Research and Human Retroviruses|August 2, 2008
Seventeen-year-old mother-to-child HIV type 1 transmission identified by phylogeny and signature patternsTerese L Katzenstein, Ann Berith Petersen, Louise Bruun Jørgensen, et al.
AIDS Research and Human Retroviruses|February 1, 2007
Investigating signs of recent evolution in the pool of proviral HIV type 1 DNA during years of successful HAARTHelene Mens, Anders G Pedersen, Louise B Jørgensen, et al.
Addiction (Abingdon, England)|April 21, 2010
Impact of injecting drug use on mortality in Danish HIV-infected patients: a nation-wide population-based cohort studyMette V Larsen, Lars H Omland, Jan Gerstoft, et al.
AIDS Research and Human Retroviruses|January 11, 2008
Characterization of near full-length genomes of HIV type 1 strains in Denmark: basis for a universal therapeutic vaccineBetina S Andresen, Lasse Vinner, Sheila Tang, et al.
Immunity & Ageing : I & A|August 6, 2015
Leptin, IL-6, and suPAR reflect distinct inflammatory changes associated with adiposity, lipodystrophy and low muscle mass in HIV-infected patients and controlsAnne Langkilde, Janne Petersen, Jens Henrik Henriksen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 29, 2015
Lower Self-Reported Quality of Life in HIV-Infected Patients on cART and With Low Comorbidity Compared With Healthy ControlsKarin K Pedersen, Morten R Eiersted, Julie C Gaardbo, et al.
AIDS (London, England)|September 23, 2003
Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosineJan Gerstoft, Ole Kirk, Niels Obel, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2018
HIV Status Is a Greater Determinant of Low Self-perceived Life Expectancy Than Cigarette Smoking in a Well-resourced SettingAndreas Ronit, Magnus G Ahlström, Andreas D Knudsen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 3, 2005
Virological control during the first 6-18 months after initiating highly active antiretroviral therapy as a predictor for outcome in HIV-infected patients: a Danish, population-based, 6-year follow-up studyNicolai Lohse, Gitte Kronborg, Jan Gerstoft, et al.
Pageof 31

Showing results (101-110 of 306) with videos related to

Sort By:
Pageof 31
Clinical Physiology and Functional Imaging|April 21, 2007
Carotid intima-media thickness in HIV patients treated with antiretroviral therapyAnne-Mette Lebech, Niels Wiinberg, Ulrik Sloth Kristoffersen, et al.
AIDS Research and Human Retroviruses|August 2, 2008
Seventeen-year-old mother-to-child HIV type 1 transmission identified by phylogeny and signature patternsTerese L Katzenstein, Ann Berith Petersen, Louise Bruun Jørgensen, et al.
AIDS Research and Human Retroviruses|February 1, 2007
Investigating signs of recent evolution in the pool of proviral HIV type 1 DNA during years of successful HAARTHelene Mens, Anders G Pedersen, Louise B Jørgensen, et al.
Addiction (Abingdon, England)|April 21, 2010
Impact of injecting drug use on mortality in Danish HIV-infected patients: a nation-wide population-based cohort studyMette V Larsen, Lars H Omland, Jan Gerstoft, et al.
AIDS Research and Human Retroviruses|January 11, 2008
Characterization of near full-length genomes of HIV type 1 strains in Denmark: basis for a universal therapeutic vaccineBetina S Andresen, Lasse Vinner, Sheila Tang, et al.
Immunity & Ageing : I & A|August 6, 2015
Leptin, IL-6, and suPAR reflect distinct inflammatory changes associated with adiposity, lipodystrophy and low muscle mass in HIV-infected patients and controlsAnne Langkilde, Janne Petersen, Jens Henrik Henriksen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 29, 2015
Lower Self-Reported Quality of Life in HIV-Infected Patients on cART and With Low Comorbidity Compared With Healthy ControlsKarin K Pedersen, Morten R Eiersted, Julie C Gaardbo, et al.
AIDS (London, England)|September 23, 2003
Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosineJan Gerstoft, Ole Kirk, Niels Obel, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2018
HIV Status Is a Greater Determinant of Low Self-perceived Life Expectancy Than Cigarette Smoking in a Well-resourced SettingAndreas Ronit, Magnus G Ahlström, Andreas D Knudsen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 3, 2005
Virological control during the first 6-18 months after initiating highly active antiretroviral therapy as a predictor for outcome in HIV-infected patients: a Danish, population-based, 6-year follow-up studyNicolai Lohse, Gitte Kronborg, Jan Gerstoft, et al.
Pageof 31